Integrated Bioinformatics Analysis Reveals the Clinical and Epigenetic Significance of PYCR1 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Lung Adenocarcinoma
Asian Journal of Applied Science and Technology · 2026 · 10 (02) · 126-140
DOI: 10.38177/ajast.2026.10210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Applied Science and Technology, 2026. Verfasst von Md. Mahbubol Alam und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) is still one of the main causes of death from cancers globally; hence, there is a need for developing new biomarkers and targets for diagnosis and treatment. This work involves analyzing the involvement of Pyrroline-5-carboxylate reductase 1 (PYCR1) through multidimensional bioinformatic approaches on LUAD data obtained from „The Cancer Genome Atlas (TCGA)‟ portal-UALCAN. Our findings indicate that PYCR1 is highly expressed in LUAD tissue samples than normal lungs (p < 1E-12) with a consistent increase in its expression irrespective of age group, gender, or smokers/non-smokers. Elevated PYCR1 was positively associated with more advanced clinical stages of tumors and lymph node metastasis. Moreover, we found that the expression of PYCR1 is highly up-regulated in response to TP53 mutations with hypomethylation of its promoter, thus implying a novel mechanism of transcriptional activation of PYCR1. Notably, the analysis showed that high expression of PYCR1 is an independent marker predicting poor survival. This makes PYCR1 a reliable biomarker with both diagnostic and prognostic value and demonstrates the significance of a metabolic-genetic axis in cancer development. The study concludes that PYCR1 proline pathway modulation can be used as a novel therapy to treat lung adenocarcinoma.
Zitieren
APA
Alam, M. M., Begum, R. T., Suvo, S. A., Anower, F. B., Nazim, S., Islam, M. F., & Ratul, M. I. M. (2026). Integrated Bioinformatics Analysis Reveals the Clinical and Epigenetic Significance of PYCR1 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Lung Adenocarcinoma. Asian Journal of Applied Science and Technology, 10(02), 126-140. https://doi.org/10.38177/ajast.2026.10210
Vancouver
Alam MM, Begum RT, Suvo SA, Anower FB, Nazim S, Islam MF, et al. Integrated Bioinformatics Analysis Reveals the Clinical and Epigenetic Significance of PYCR1 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Lung Adenocarcinoma. Asian Journal of Applied Science and Technology. 2026;10(02):126-140. doi:10.38177/ajast.2026.10210
BibTeX
@article{Alam2026,
author = {Alam, Md. Mahbubol and Begum, Rifah Tamanna and Suvo, Sumon Ahmed and Anower, Fahamida Binta and Nazim, Sahariare and Islam, Md. Fardin and Ratul, Md. Imam Mahdi},
title = {Integrated Bioinformatics Analysis Reveals the Clinical and Epigenetic Significance of PYCR1 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Lung Adenocarcinoma},
journal = {Asian Journal of Applied Science and Technology},
year = {2026},
volume = {10},
number = {02},
pages = {126--140},
doi = {10.38177/ajast.2026.10210}
}
EUVIMED